Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Information

The tables below present segment information reconciled to total Company loss from operations, with segment operating loss including gross profit less direct research and development expenses and direct selling, general and administrative expenses to the extent specifically identified by segment:

	Year Ended December 31, 2018
		Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues		$	5,687,000		$	-		$	5,687,000
Gross margin			3,203,000			-			3,203,000
Research and development expenses			808,000			731,000			1,539,000
Depreciation and amortization expense			163,000			-			163,000
Selling, general and administrative expenses			4,340,000			177,000			4,517,000
Total operating expenses			(5,311,000	)		(908,000	)		(6,219,000	)
Loss from operations		$	(2,108,000	)	$	(908,000	)	$	(3,016,000	)

	Year Ended December 31, 2017
		Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues		$	3,809,000		$	-		$	3,809,000
Gross margin			2,292,000			-			2,292,000
Research and development expenses			970,000			32,000			1,002,000
Depreciation and amortization expense			218,000			-			218,000
Selling, general and administrative expenses			3,286,000			12,000			3,298,000
Total operating expenses			(4,474,000	)		(44,000	)		(4,518,000	)
Loss from operations		$	(2,182,000	)	$	(44,000	)	$	(2,226,000	)